INLYTA
202324 | Orange Book
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Patent | Expiration |
---|---|
6,534,524 | 3 months from now |
6,534,524 | 9 months, 1 week from now |
8,791,140 | 5 years, 10 months from now |
8,791,140 | 6 years, 4 months from now |
10,570,202 | 10 years from now |
10,570,202 | 10 years, 6 months from now |
10,869,924 | 11 years, 11 months from now |
10,869,924 | 12 years, 5 months from now |
Date | Patent / Filing No. | Patent and Drug Application Information |
---|---|---|
7/12/2037 | 10869924 | Expiration of Patent No 10,869,924: Has Pediatrict Exclusivity. |
1/12/2037 | 10869924 | Expiration of Patent No 10,869,924: (U-3044). |
8/3/2035 | 10570202 | Expiration of Patent No 10,570,202: Has Pediatrict Exclusivity. |
2/3/2035 | 10570202 | Expiration of Patent No 10,570,202: (U-2844). |
6/14/2031 | 8791140 | Expiration of Patent No 8,791,140: Has Pediatrict Exclusivity. |
12/14/2030 | 8791140 | Expiration of Patent No 8,791,140: |
10/29/2025 | 6534524 | Expiration of Patent No 6,534,524: Has Pediatrict Exclusivity. |
4/29/2025 | 6534524 | Expiration of Patent No 6,534,524: (drug product) |
7/16/2024 | SUPPL-16 | Labeling-Package Insert: |
9/22/2022 | SUPPL-14 | Efficacy-Labeling Change With Clinical Data: |
6/4/2020 | SUPPL-11 | Efficacy-New Indication: |
1/23/2020 | SUPPL-10 | Labeling-Package Insert: |
8/10/2018 | SUPPL-8 | Labeling-Package Insert: |
6/16/2016 | SUPPL-5 | Manufacturing (CMC): Label is not available on this site. |
3/30/2016 | SUPPL-4 | Manufacturing (CMC): Label is not available on this site. |
12/29/2014 | SUPPL-3 | Labeling-Container/Carton Labels: |
8/1/2014 | SUPPL-2 | Labeling-Package Insert: |
9/16/2013 | SUPPL-1 | Labeling-Package Insert: |
1/27/2012 | Approval for INLYTA, 5MG
| |
1/27/2012 | Approval for INLYTA, 1MG
| |
1/27/2012 | ORIG-1 | Approval:
|